The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111300635 11130063 5 F 20150410 20160708 20150521 20160719 EXP PHHO2015FR008901 NOVARTIS 82.06 YR M Y 62.50000 KG 20160719 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111300635 11130063 1 PS EVEROLIMUS EVEROLIMUS 1 Oral 2 MG, BID Y 21560 2 MG TABLET BID
111300635 11130063 2 SS EVEROLIMUS EVEROLIMUS 1 Oral 0.75 MG, BID Y 21560 .75 MG TABLET BID
111300635 11130063 3 SS TACROLIMUS. TACROLIMUS 1 Oral 5 MG, BID Y 0 5 MG BID
111300635 11130063 4 SS TACROLIMUS. TACROLIMUS 1 Oral UNK Y 0
111300635 11130063 5 SS TACROLIMUS. TACROLIMUS 1 Oral 1 MG, BID Y 0 1 MG BID
111300635 11130063 6 C SIMULECT BASILIXIMAB 1 Intravenous (not otherwise specified) 20 MG, TWICE (D0 AND D4) 0 20 MG
111300635 11130063 7 C PREDNISOLONE. PREDNISOLONE 1 Oral 10 MG, QD Y 0 10 MG QD
111300635 11130063 8 C PREDNISOLONE. PREDNISOLONE 1 Oral 5 MG, UNK Y 0 5 MG
111300635 11130063 9 C AMLOR AMLODIPINE BESYLATE 1 Oral 5 MG, QD 0 5 MG QD
111300635 11130063 10 C EUPANTOL PANTOPRAZOLE SODIUM 1 Oral 20 MG, QD 0 20 MG QD
111300635 11130063 11 C ARANESP DARBEPOETIN ALFA 1 Subcutaneous 60 UG, QW Y 0 60 UG /wk
111300635 11130063 12 C ARANESP DARBEPOETIN ALFA 1 Subcutaneous UNK Y 0
111300635 11130063 13 C NOVONORM REPAGLINIDE 1 Oral 1 MG, BID 0 1 MG BID
111300635 11130063 14 C MOVICOL POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE 1 Unknown 1 DF, UNK (1 SACHET/DAY IF CONSTIPATION) U 0 1 DF

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111300635 11130063 1 Renal transplant
111300635 11130063 3 Renal transplant
111300635 11130063 6 Renal transplant
111300635 11130063 7 Renal transplant
111300635 11130063 9 Hypertension
111300635 11130063 10 Gastrooesophageal reflux prophylaxis
111300635 11130063 11 Anaemia
111300635 11130063 13 Diabetes mellitus
111300635 11130063 14 Constipation

Outcome of event

Event ID CASEID OUTC COD
111300635 11130063 OT
111300635 11130063 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
111300635 11130063 Complications of transplanted kidney
111300635 11130063 Diabetes mellitus
111300635 11130063 General physical health deterioration
111300635 11130063 Hypochromic anaemia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111300635 11130063 1 20150303 0
111300635 11130063 2 20150608 0
111300635 11130063 3 20150303 0
111300635 11130063 4 20150511 0
111300635 11130063 5 20150605 0
111300635 11130063 6 20150303 20150307 0
111300635 11130063 7 20150303 0
111300635 11130063 8 20150606 0
111300635 11130063 9 20150310 0
111300635 11130063 10 20150305 0
111300635 11130063 11 20150421 0
111300635 11130063 12 20150608 0
111300635 11130063 13 20150506 0
111300635 11130063 14 20150515 0